Interests of Bayesian Approaches for the Analysis and Summary of Adverse Event Data Recorded in Randomized Phase III Clinical Trials

Louis Jacob^1,2, Marion Caceres³, Morgane Gilles³, Léa Poulmarch³ and Sylvie Chevret^1*

¹Biostatistics and Clinical Epidemiology team (ECSTRA), of the Center of Research on Epidemiology and Biostatistics Sorbonne Paris Cité (CRESS; INSERM UMR 1153), Paris Diderot University, Paris, France, E-mail: sylvie.chevret@paris7.jussieu.fr

²École Normale Supérieure de Lyon, France, E-mail: sylvie.chevret@paris7.jussieu.fr

³École Nationale de la statistique et de l'analyse de l'information, Rue Blaise Pascal, Rennes, France, E-mail: sylvie.chevret@paris7.jussieu.fr

^*Corresponding Author: Sylvie Chevret, Biostatistics and Clinical Epidemiology team (ECSTRA) of the Center of Research on Epidemiology and Biostatistics Sorbonne Paris Cité (CRESS; INSERM UMR 1153), Paris Diderot University, Paris, France Email: